Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Context: Infection with hepatitis C virus (HCV) is one of the most important risk factors of hepatocellular carcinoma
(HCC). HCV is suspected to induce HCC primarily through chronic inflammation and promotion of cirrhosis. However, the
pathogenesis of insulin resistance (IR) in hepatitis C infection is a very intriguing problem. In fact, the HCV is now recognized
responsible for direct interference with the insulin signaling pathway. In addition, HCV-related IR has been shown to have a
remarkable clinical impact on the progression of hepatic fibrosis and development of HCC. In the liver, HCV core protein upregulates
suppressor of cytokine signaling (SOCS-3) and (SOCS-1), which are known to inhibit insulin signaling by causing
ubiquitination of insulin receptor substrate (IRS-1) and (IRS-2) proteins. Genetic variations affecting this gene can induce
insulin resistance and decrease the response to interferon, both can accelerated the process of liver carcinogenesis.
Objective: This study aims to evaluate the association between SOSC-3 polymorphisms and progression liver fibrosis in
chronic hepatitis C infected patients.
Materials & Methods: In this study, 208 patients chronically infected with HCV (92 patients with moderate fibrosis and 116
patients with advanced fibrosis) were genotyped for 4874 A/G (rs4969170) and A+930-->G (rs4969168) variants using the real
time PCR.
Results: A significant difference in genotype distribution of rs4969168 and rs4969170 were detected between mild and
advanced fibrosis group. Although these results of SNP genotyping showed that the AA and GA genotypes are increased in
advanced fibrosis patients compared to mild fibrosis patients for both SNPs.
Conclusion: These findings indicated that recipient genetic factors play a role in HCV-related fibrosis progression. Molecular
studies of these pathways may elucidate the pathogenesis of fibrosis progression and provide risk prediction markers.